Events

Views Navigation

Event Views Navigation

Today
  • Jornada Internacional SAEGRE 2026

    Universidad Católica Argentina - Buenos Aires

    SAEGRE invita a participar de una nueva edición de su Jornada Internacional, un espacio de actualización y encuentro científico para profesionales de la especialidad. 📅 5 de septiembre de 2026 📍 Universidad Católica Argentina – Buenos Aires Una jornada para compartir conocimiento, experiencias y avances en endocrinología ginecológica y reproductiva.

  • The Metabolic Woman: From Mechanisms to Precision Care in Gynecological Endocrinology

    This 12-lecture course explores metabolism as a central regulator of female reproductive endocrinology, gynecological health, fertility, pregnancy, menopause, and healthy aging. The series is designed to combine state-of-the-art pathophysiology with immediately applicable clinical management strategies, translating metabolic science into practical decision-making for specialists in gynecology, reproductive medicine, endocrinology, and women’s health. Course Rationale Metabolic hormones […]

  • Menopause and the pelvic floor

    Moderator: Prof. Tommaso Simoncini Speakers: Prof. Eleonora Russo The link between menopause and lower urinary tract symptoms Prof. Santiago Palacios Hormonal and non-hormonal management of GSM

  • PCOS: therapeutical challenges

    Moderator: Prof. Sarah Berga  Speakers: Prof. Blazej Meczekalski Neuroendocrinological aspects of hormonal contraception in PCOS Prof. Alessandro Genazzani The choice of correct integrative approach for insulin resistance in PCOS

  • Challenges in the management of adenomiosis

    Moderator: Prof. Tommaso Simoncini Speakers: Prof. Felice Petraglia What is adenomiosis and how can it be managed? Prof. Stefano Angioni Fertility and infertility in women with adenomiosis

  • Breast Cancer Risk and HRT

    Moderator: Prof. Richard J Santen Speakers: Prof. Alfred Mueck New concepts in breast cancer hormonal dependency Prof. Anne Gompel Understanding the impact of HRT on breast cancer risk